Physician profile
Albert Mathieu
NPI 1538819818
$545.43
in general payments reported to CMS, 2019-2025
9 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $300 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $159.66 | 2024-2025 | Bexsero, Pediarix, Penmenvy |
| Merck Sharp & Dohme LLC | $81.48 | 2024-2025 | Gardasil 9, Enflonsia, Rotateq |
| Pfizer INC. | $65.40 | 2024-2025 | |
| Sanofi Pasteur INC. | $65.24 | 2024-2025 | |
| Cranial Technologies, INC | $60.39 | 2024-2025 | Doc Band |
| Exact Sciences Corporation | $42.28 | 2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $29.93 | 2024 | Elaprase |
| Biomarin Pharmaceutical INC. | $27.20 | 2025 | Voxzogo 1.2mg |
| Seqirus USA INC | $13.85 | 2024 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Mathieu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.